Please try another search
ADIMMUNE CORPORATION is a Taiwan-based company principally engaged in the research and development, processing, manufacture and trading of influenza vaccine products and non-flu vaccine products. The Company's products include Japanese encephalitis vaccines, tetanus vaccines, influenza vaccines, H1N1 influenza vaccines and tuberculin. The vaccine products are applied in the prevention of various infectious viruses. The tuberculin is applied in tuberculin purified protein derivative (PPD) test. The Company distributes its products within domestic market and to overseas markets, including other markets in Asia, Europe and Africa.
Name | Age | Since | Title |
---|---|---|---|
Jung-Chin Lin | 67 | 2019 | Director |
Mei-Hsing Tseng | - | 2017 | Director |
Wei-Kuang Chi | - | 2001 | Director |
Chien-Fu Chen | - | 2017 | Director |
Chung-Cheng Liu | - | 2012 | President, GM & Director |
Hsiao-Po Hsu | - | 2011 | Independent Director |
Chi-Heng Lin | - | 2008 | Director |
Chi-Hsien Chan | - | 2008 | CEO & Chairman |
Yung-Sheng Hsu | - | 2020 | Independent Director |
Mei-Hsiang He | - | 2017 | Independent Director |
Feng Xiang Yang | - | - | Member of Supervisory Board |
Ming Liang Guo | - | - | Member of Supervisory Board |
Chi-Lin Wei | 75 | - | Member of Supervisory Board |
Der-Sheng Lin | - | 2023 | Institutional Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review